Status:

SUSPENDED

Pilot Study on the Feasibility of Systematic Hepatitis C Screening of Hospitalized Patients

Lead Sponsor:

Centre Hospitalier Intercommunal Creteil

Collaborating Sponsors:

Association Nationale des Hépato-Gastroentérologues des Hôpitaux Généraux

Conditions:

Hepatitis C

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The Ministry of Health has set the target of eradicating hepatitis C (HCV) in France by 2025. The goal is to validate the feasibility and value of conducting routine HCV screening in hospitalized pat...

Detailed Description

The number of undetected HCV-infected persons has been extrapolated to 75,000 according to the results of a 2014 study. Screening efforts have been set up in groups of people said to be at high viral ...

Eligibility Criteria

Inclusion

  • Patient over 18 years of age
  • Hospitalized during the study period
  • Non-opposition for participation in the Protocol

Exclusion

  • Patients under 18 years of age
  • Outpatient, long-stay, maternity and intensive care inpatients
  • Patients refusing blood collection
  • Patient may not understand the information sheet
  • Patient under guardianship

Key Trial Info

Start Date :

September 21 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 21 2026

Estimated Enrollment :

2500 Patients enrolled

Trial Details

Trial ID

NCT04405024

Start Date

September 21 2020

End Date

June 21 2026

Last Update

July 3 2025

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

CHI Créteil

Créteil, France, 94000

2

Grand Hôpital de l'Est Francilien - Site de Marne-la-Vallée

Jossigny, France

3

CH Meaux

Meaux, France

4

CHIV

Villeneuve-Saint-Georges, France